XIIKIN

Welcome to the Brand page for “XIIKIN”, which is offered here for Protein based pharmaceutical for treating disorders of the immune system or for stimulating the immune system;.

Its status is currently believed to be active. Its class is unavailable. “XIIKIN” is believed to be currently owned by “GENETICS INSTITUTE, INC.”


Owner:
GENETICS INSTITUTE, INC.
Owner Details
Description:
Protein based pharmaceutical for treating disorders of the immune system or for stimulating the immune system;
Categories: PROTEIN BASED PHARMACEUTICAL TREATING